European Journal of Chemistry

Novel approach for preparing nontoxic stealth microspheres for drug delivery



Main Article Content

Pawan Kumar Angra
Syed Asad Ali Rizvi
Carl William Oettinger
Martin Joaquim D’Souza

Abstract

Polyethylene glycol 2000 (PEG) entrapped, bovine serum albumin (BSA) microspheres were prepared and optimized. These microspheres were then analyzed to understand the stealth effect to the microspheres imparted by incorporated polyethylene glycol (PEG). Microsphere preparations (formulations) were studied for particle size, zeta potential, free BSA content, and in-vitro uptake by human micro-vascular endothelial cells (HMECs). The results demonstrate, a formulation containing 37.5 % PEG (w/w) exhibits an acceptable particle size of <5 µm, good suspendibility with zeta potential of -35 mV, and confers some degree of stealth property to the microspheres. These non-toxic, biodegradable and long circulating microspheres have the potential to be used for extended intravenous (IV) drug delivery. Statistical analysis done by ANOVA and results with p<0.05 were considered significant.2_2_125_129_800


icon graph This Abstract was viewed 1852 times | icon graph Article PDF downloaded 684 times

How to Cite
(1)
Angra, P. K.; Rizvi, S. A. A.; Oettinger, C. W.; D’Souza, M. J. Novel Approach for Preparing Nontoxic Stealth Microspheres for Drug Delivery. Eur. J. Chem. 2011, 2, 125-129.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. D’Souza, M. J.; Oettinger, C. W.; Milton, G. V. Drug Dev. Ind. Pharm. 1999, 25, 727-734.
doi:10.1081/DDC-100102232
PMid:10349558

[2]. Haswani, D. K.; Nettey, H.; Oettinger, C. W.; D'Souza, M. J. J. Microencapsul. 2006, 23, 875-886.
doi:10.1080/02652040601035093
PMid:17390629

[3]. Nettey, H.; Haswani, D. K.; Oettinger, C. W.; D'Souza, M. J. J. Microencapsul. 2006, 23, 632-642.
doi:10.1080/02652040600776564
PMid:17118879

[4]. Haswani, D. K.; Nettey, H.; D'Souza. M, J.; Oettinger, C. W. Drug Dev. Ind. Pharm. 2007, 33, 181-190.
doi:10.1080/03639040600865249
PMid:17454050

[5]. Lai, Y. H.; D'Souza. M, J. J. Microencapsul. 2007, 24, 235-252.
doi:10.1080/02652040601162608
PMid:17454435

[6]. Oettinger, C. W.; D’Souza, M. J.; Akhavein. N.; Pee, G. T.; Taylor, F. B.; Kinasewitz, G. T. J. Microencapsul. 2007, 24, 337-348.
doi:10.1080/02652040601162525
PMid:17497387

[7]. Zhaowei, J.; D’Souza, M. J.; Oettinger, C. W. J. Microencapsul. 2007, 24, 596-607.
doi:10.1080/02652040701453477
PMid:17654178

[8]. Kramer, P. A. J. Pharm. Sci. 1974, 63, 1646-1647.
doi:10.1002/jps.2600631044
PMid:4436811

[9]. Tomilson, E.; Schoolderwoerd, E. M. A.; McVie, J. G. Human serum albumin microspheres for intra-arterial drug targeting of cytostatic compounds. Microspheres and Drug Therapy, Ed. Davis, S. S. Amsterdam, The Netherlands Elsevier, pp. 75-91, 1984.

[10]. Gref, R.; Quellec, P.; Blunk, T.; Muller, R. H.; Verbavatz, J. M.; Langer, R. Adv. Drug. Deliv. Rev. 1995, 16, 215-233.
doi:10.1016/0169-409X(95)00026-4

[11]. Moghimi, S. M.; Hunter, C.; Murray, J. C. Pharmacol. Rev. 2001, 53, 283-318.
PMid:11356986

[12]. Huh, K. M.; Cho, Y. W.; Park, K. Drug Deliv. Tech. 2003, 3(5), URL: http://drugdeliverytech.com

[13]. Zara, G. P.; Bargoni. A.; Fundaro, A.; Vighetto, D.; Gasco, M. R. J. Drug Target. 2002, 10, 327-335.
doi:10.1080/10611860290031868
PMid:12164381

[14]. Marino, D. Drug Deliv. Tech. 2003, 3(5), URL: http://drugdeliverytech.com

[15]. Vladimir, P. T.; Trubetskoy, V. S. Adv. Drug. Deliv. Rev. 1995, 16, 141-155.
doi:10.1016/0169-409X(95)00022-Y

[16]. Stolnik, S.; Illum, L.; Davis, S. S. Adv. Drug. Deliv. Rev. 1995, 16, 195-214.
doi:10.1016/0169-409X(95)00025-3

[17]. Ho, E. A.; Ramsay, E.; Ginj, M.; Anantha, M.; Bregman, I.; Sy, J.; Woo, J.; Osooly-Talesh, M.; Yapp, D. T.; Bally, M. B. J. Pharm. Sci. 2010, 99, 2839-2853.
doi:10.1002/jps.21845
PMid:19569058

[18]. Ades, E. W.; Candal, F. J.; Swerlick, R. A.; George, V. G.; Summer, S.; Bosse, D. C.; Lawley, T. J. J. Invest. Dermatol. 1992, 99, 683-690.
doi:10.1111/1523-1747.ep12613748
PMid:1361507

[19]. Udenfriend, S. Science 1972, 178, 871-872.
doi:10.1126/science.178.4063.871
PMid:5085985

[20]. Sigma-Aldrich. Fluorescamine. Product Information Sheet # F9015, 2005.

Supporting Agencies

Most read articles by the same author(s)

Most read articles by the same author(s)

TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).